The Psyence™ Group sets the global standard for natural psychedelics.
Informed by nature and guided by science, Psyence is a life science biotechnology company pioneering the use of natural psilocybin to heal psychological trauma and the diagnosable disorders that can result: anxiety, depression, PTSD, stress, grief and bereavement. We have a focus on these conditions in the context of palliative care.
We are focused on the development of psilocybin medical products for research institutions and clinics and will also manufacture regulatory-compliant over the counter psilocybin containing products. We are also developing nutraceutical products for depression, acute anxiety and sleep disorders.
Psyence is listed on the Canadian Stock Exchange (CSE: PSYG) and our diversified business has a global footprint with operations in multiple legal jurisdictions. We operate one of the first federally licensed commercial psilocybin cultivation and production facilities in the world in Southern Africa.
The Psyence™ Group sets the global standard for natural psychedelics.
Informed by nature and guided by science, Psyence is a life science biotechnology company pioneering the use of natural psilocybin to heal psychological trauma and the diagnosable disorders that can result: anxiety, depression, PTSD, stress, grief and bereavement. We have a focus on these conditions in the context of palliative care.
We are focused on the development of psilocybin medical products for research institutions and clinics and will also manufacture regulatory-compliant over the counter psilocybin containing products. We are also developing nutraceutical products for depression, acute anxiety and sleep disorders.
Psyence is listed on the Canadian Stock Exchange (CSE: PSYG) and our diversified business has a global footprint with operations in multiple legal jurisdictions. We operate one of the first federally licensed commercial psilocybin cultivation and production facilities in the world in Southern Africa.
Psyence is pioneering the use of natural psilocybin for the long-term treatment of trauma and its mental health consequences.
Bringing together leaders in the business of medicine and science
Our scientific and medical team, which includes experts in neurology, neuroscience, oncology and drug development, have international expertise in palliative medicine and science. Our global executive team has extensive capital market and business building experience and a track record for creating shareholder value and achieving sustainable growth.
Our News
Psyence Group Announces GoldCoast Resource Closes Second Tranche of Offering
GoldCoast has completed a brokered private placement raising $5.8 million, meeting a key condition for its proposed amalgamation with Psyence.
Psyence Group Inc. Provides Update on Proposed Amalgamation with GoldCoast Resource Corp.
GoldCoast has completed a brokered private placement raising $5.8 million, meeting a key condition for its proposed amalgamation with Psyence.
Psyence Group Inc. Enters into Amending Agreement to Extend Amalgamation Timeline with GoldCoast Resource Corp.
Psyence Group Inc. has entered into an Amending Agreement with GoldCoast Resource Corp. to revise the previously announced November 2025 Amalgamation Agreement.
Our News
Psyence Group Announces GoldCoast Resource Closes Second Tranche of Offering
GoldCoast has completed a brokered private placement raising $5.8 million, meeting a key condition for its proposed amalgamation with Psyence.
Psyence Group Inc. Provides Update on Proposed Amalgamation with GoldCoast Resource Corp.
GoldCoast has completed a brokered private placement raising $5.8 million, meeting a key condition for its proposed amalgamation with Psyence.
Psyence Group Inc. Enters into Amending Agreement to Extend Amalgamation Timeline with GoldCoast Resource Corp.
Psyence Group Inc. has entered into an Amending Agreement with GoldCoast Resource Corp. to revise the previously announced November 2025 Amalgamation Agreement.
Our Global Footprint
Our team and operations are located across Toronto, Canada; Washington DC, United States of America; Cape Town, South Africa; Kolojane, Kingdom of Lesotho; Kingston, Jamaica; London United Kingdom; Sydney, Australia and Sao Paulo, Brazil.